Basilea Pharmaceutica AG
SIX:BSLN
Intrinsic Value
The intrinsic value of one
BSLN
stock under the Base Case scenario is
44.89
CHF.
Compared to the current market price of 52.1 CHF,
Basilea Pharmaceutica AG
is
Overvalued by 14%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Basilea Pharmaceutica AG.
The intrinsic value of one
BSLN
stock under the Base Case scenario is
44.89
CHF.
Compared to the current market price of 52.1 CHF,
Basilea Pharmaceutica AG
is
Overvalued by 14%.